McDermott Will & Emery Represents Flourish Research in a Majority Investment From Genstar Capital
September 25, 2024
September 25, 2024
CHICAGO, Illinois, Sept. 25 -- McDermott Will and Emery, a law firm, issued the following news release:
International law firm McDermott Will & Emery represented NMS Capital (NMS) and its portfolio company Flourish Research (Flourish), a leading multi-site clinical trial organization focused on cardiovascular, metabolic, neuroscience and infectious disease therapeutic areas among others, in a strategic majority investment from Genstar Capital (Genstar), a leading private equity . . .
International law firm McDermott Will & Emery represented NMS Capital (NMS) and its portfolio company Flourish Research (Flourish), a leading multi-site clinical trial organization focused on cardiovascular, metabolic, neuroscience and infectious disease therapeutic areas among others, in a strategic majority investment from Genstar Capital (Genstar), a leading private equity . . .